| 细粒棘球绦虫抗原B重组蛋白的免疫反应性 |
| |
| 引用本文： | 吕国栋,刘涛,林仁勇,王星,王俊华,任智慧,温浩,卢晓梅.细粒棘球绦虫抗原B重组蛋白的免疫反应性[J].中国寄生虫学与寄生虫病杂志,2009,27(2):107-110. |
| |
| 作者姓名： | 吕国栋 刘涛 林仁勇 王星 王俊华 任智慧 温浩 卢晓梅 |
| |
| 作者单位： | 新疆医科大学第一附属医院医学研究中心,新疆包虫病基础医学重点实验室,乌鲁木齐 830054 |
| |
| 摘 要： | 目的 利用基因工程方法表达细粒棘球绦虫抗原B重组蛋白（rAgB）,并分析其免疫反应性。 方法 将rAgB基因片段插入原核表达载体pET41a（+）中,转化大肠埃希菌BL21（DE3）菌株,经异丙基-β-D-硫代半乳糖苷（IPTG）诱导表达,获得重组蛋白rAgB-GST。用谷胱甘肽琼脂糖树脂亲和层析柱（GST-sepharose 4B）纯化,经十二烷基硫酸钠-聚丙烯酰胺凝胶电泳（SDS-PAGE）分析重组蛋白的表达情况。用蛋白质印迹（Western blotting）分析其免疫反应性,并用免疫胶体金包虫诊断试剂盒作为对照。 结果 PCR、双酶切及DNA测序结果均显示重组质粒pET41a-rAgB构建成功。SDS-PAGE结果表明,重组蛋白rAgB-GST的相对分子质量（Mr）为40 800,纯化蛋白含量为78.4%。Western blotting分析结果显示,重组蛋白rAgB-GST检测细粒棘球蚴病和多房棘球蚴病患者血清的阳性率分别为79.2%（95/120）和51.1%（23/45）,但与卫氏并殖吸虫病患者、华支睾吸虫病患者血清以及健康人血清反应均为阴性。rAgB-GST的敏感性和特异性分别为79.2％（95/120）和81.0%（98/121）,均略高于免疫胶体金棘球蚴病诊断试剂盒的敏感性(72.8%,75/103）和特异性（76.9%,30/39）。 结论 重组rAgB-GST蛋白可被细粒棘球蚴病和多房棘球蚴病患者血清识别,有较好的免疫反应性。
|
| 关 键 词： | 细粒棘球绦虫 重组抗原B 免疫诊断 |
Immunoreactivity of the Recombinant Protein of Echinococcus granulosus Antigen B |
| |
| LV Guo-dong,LIU Tao,LIN Ren-yong,WANG Xing,WANG Jun-hua,REN Zhi-hui,WEN Hao,LU Xiao-mei.Immunoreactivity of the Recombinant Protein of Echinococcus granulosus Antigen B[J].Chinese Journal of Parasitology and Parasitic Diseases,2009,27(2):107-110. |
| |
| Authors: | LV Guo-dong LIU Tao LIN Ren-yong WANG Xing WANG Jun-hua REN Zhi-hui WEN Hao LU Xiao-mei |
| |
| Affiliation: | Medical Research Center,the First Teaching Hospital of Xinjiang Medical University,Urumqi 830054,China |
| |
| Abstract: | Objective To express the recombinant antigen B（rAgB）of Echinococcus granulosus（Eg）and investigate its immunoreactivity. Methods The rAgB gene fragments were inserted into pET41a（+）prokaryotic vector. The recombinant plasmid was transformed into E. coli BL21（DE3）and followed by expression of the protein induced by isopropyl β-D-1-thiogalactopyranoside（IPTG）. The protein was purified with sepharose 4B by affinity chromatography, and tested by SDS-PAGE electrophoresis. Its immunoreactivity was examined by Western blotting, and a rapid diagnosis kit for human echinococcosis was used as control. Results The constructed recombinant plasmid pET41a-rAgB was identified by PCR, digestion with restriction enzyme and sequencing. The recombinant rAgB-GST was about Mr 40 800 with a purity of 78.4%. Western blotting showed that the positive rate of rAgB-GST reacting with sera of cystic echinococcosis（CE）, alveolar echinococcosis（AE）, paragonimiasis westermani and clonorchiasis sinensis patients, and healthy persons is 79.2%（95/120）, 51.1%（23/45）, 0（0/32）, 0（0/20）, and 0（0/24）, respectively. Its overall sensitivity and specificity were 79.2%（95/120） and 81.0%（98/121）, respectively, slightly higher than the sensitivity（72.8%, 75/103） and specificity （76.9%, 30/39）of the rapid diagnosis kit for human echinococcosis. Conclusion The rAgB-GST recombinant protein is recognized by the sera of CE and AE patients, showing a proper immunoreactivity. |
| |
| Keywords: | Echinococcus granulosus Recombinant antigen B Echinococcus granulosus" target="_blank">Immunodiagnosis')">Echinococcus granulosus Recombinant antigen B Immunodiagnosis |
|
| 点击此处可从《中国寄生虫学与寄生虫病杂志》浏览原始摘要信息 |
|
点击此处可从《中国寄生虫学与寄生虫病杂志》下载全文 |
|
